A129CI1.05-1.89; p= 0.024). MI were slightly less likely to schedule DFE vs. UC (38% vs. 42%, RR0.90; CI0.66-1.22; p= NSS) and attend DFE (32% vs. 36%; RR0.90; CI 0.63-1.28; p= NSS).
patients very unhappy starting insulin were less likely to be on injectable GLP-1 therapy, receiving fewer non-insulin products and had existing concerns around injections. However, 83.42% of patients taking insulin report feeling better since starting insulin citing improved blood glucose control (68.95%) and more energy (50.52%) as main reasons. Overall, patient's feelings towards currently taking insulin were more positive (very/fairly happy: PCP 47.44%; ENDO 42.49%). Patients happy taking insulin versus unhappy reported higher compliance (Morisky Medication Adherence Scale), improved well-being, fewer problems taking injections and fewer medications. ConClusions: Pre-insulin users have higher concerns towards taking insulin compared to those currently receiving insulin. Insulin patient's concern levels around therapy improve due to positive experiences around feeling better. It would appear exposure to other injectable therapy ahead of insulin mitigates preinsulin patient concerns towards insulinization. Positive insulin experiences result in improved adherence to medication.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.